ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.90
-0.22%
Dow Jones
40,954.48
1.85%
Gold vs US Dollar
2,469.02
1.93%
Brent Oil
83.315
-1.22%
Bitcoin
64,675.27
-0.27%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) News

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
25/05/200621:33PR Newswire (US)Allos Therapeutics Reports Restricted Stock Grant Under Nasdaq Marketplace Rule 4350NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/05/200613:00PR Newswire (US)Allos Therapeutics Reports First Quarter 2006 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/04/200613:00PR Newswire (US)Interim Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 3 TrialNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/03/200613:00PR Newswire (US)Allos Therapeutics Appoints Paul L. Berns as President and CEONASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/03/200613:00PR Newswire (US)Allos Therapeutics Reports 2005 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/03/200613:00PR Newswire (US)Allos Therapeutics to Present at the 2006 Cowen Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
14/02/200613:00PR Newswire (US)Scheduled Combination of Allos Therapeutics' Pralatrexate Plus Gemcitabine Proves Superior to Methotrexate Plus Cytarabine in MoNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/02/200613:00PR Newswire (US)Allos Therapeutics to Present at the 2006 BIO CEO & Investor ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/01/200600:22PR Newswire (US)Allos Therapeutics Announces CEO Succession PlansNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/01/200613:00PR Newswire (US)Results Published in Journal of Clinical Oncology Affirm Survival Benefit of EFAPROXYN(TM) in Patients with Brain Metastases OriNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/12/200513:02PR Newswire (US)Retrospective Analysis Finds EFAPROXYN(TM) Extends Survival With Quality of Life in Patients With Brain Metastases Originating FNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/12/200513:00PR Newswire (US)PDX Shows Promising Activity in Patients With Resistant T-Cell LymphomasNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/11/200513:02PR Newswire (US)Allos Therapeutics Appoints Timothy P. Lynch to Board of DirectorsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
17/11/200513:01PR Newswire (US)Interim Phase 1 Data on RH1 Presented at AACR-NCI-EORTC ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/11/200513:00PR Newswire (US)Data From Phase 1 Clinical Trial of PDX (Pralatrexate) to be Presented at American Society of Hematology Annual MeetingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
09/11/200513:02PR Newswire (US)Allos Therapeutics Reports Third Quarter 2005 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/11/200513:02PR Newswire (US)Data on EFAPROXYN(TM) and RH1 to be Presented at Upcoming Scientific ConferencesNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/10/200517:02PR Newswire (US)Allos Therapeutics Announces Dismissal of Securities Class Action LawsuitNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/200514:01PR Newswire (US)Allos Therapeutics to Present at the 2005 BIO Investor ForumNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/10/200523:06PR Newswire (US)Allos Therapeutics Announces Withdrawal of European Marketing Authorization Application for REVAPROXYN(TM)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/09/200514:00PR Newswire (US)Allos Therapeutics to Present at the UBS Global Life Sciences ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/09/200514:02PR Newswire (US)Allos Therapeutics to Present at the Bear Stearns Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/09/200514:00PR Newswire (US)Results Published in Journal of Clinical Oncology Demonstrate Survival Benefit of EFAPROXYN(TM) in Treating NSCLC Patients ReceiNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/08/200514:01PR Newswire (US)Allos Therapeutics Reports Second Quarter 2005 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
16/06/200520:28PR Newswire (US)Allos Therapeutics and Hovione Enter Into Manufacturing Agreement for EFAPROXYN(TM) Bulk Drug SubstanceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
19/05/200523:46PR Newswire (US)Allos Therapeutics Announces Stockholder Approval of Share ExchangeNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
19/05/200514:00PR Newswire (US)Allos Therapeutics to Present at the Needham & Company Biotechnology ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/05/200514:01PR Newswire (US)Allos Therapeutics Reports First Quarter 2005 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/03/200511:00PR Newswire (US)Allos Therapeutics to Present at SG Cowen's Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/03/200511:02PR Newswire (US)Allos Therapeutics Reports 2004 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Your Recent History

LSE
GDR
Genedrive
LSE
PRU
Prudential
LSE
CPX
Cap-xx
LSE
LLOY
Lloyds Banking
LSE
POS
Plexus
LSE
VAST
Vast Resources
LSE
OCDO
Ocado
LSE
GWMO
Great Western Mining
LSE
AAZ
Anglo Asian Mining
LSE
ITM
Itm Power
LSE
GKP
Gulf Keystone Petroleum
LSE
ENET
Ethernity Networks
LSE
SCLP
Scancell
LSE
HE1
Helium One Global
LSE
SYME
Supply@me Capital
LSE
KOD
Kodal Minerals
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved